Parallax Volatility Advisers
TEVA icon

Parallax Volatility Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Parallax Volatility Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117,708
Closed -$3.67M – 1827
2025
Q4 		$3.67M Buy
117,708
+65,266
+124% +$1.61M 0.01% 761
2025
Q3 		$1.06M Sell
52,442
-36,795
-41% -$646K ﹤0.01% 1088
2025
Q2 		$1.5M Sell
89,237
-41,300
-32% -$666K ﹤0.01% 967
2025
Q1 		$2.01M Sell
130,537
-1,004,695
-89% -$17.9M 0.01% 868
2024
Q4 		$25M Buy
1,135,232
+258,551
+29% +$4.7M 0.05% 307
2024
Q3 		$15.8M Buy
876,681
+39,394
+5% +$689K 0.03% 392
2024
Q2 		$13.6M Buy
+837,287
New +$12.9M 0.03% 386
2024
Q1 		– Sell
-358,040
Closed -$4.51M – 2352
2023
Q4 		$3.74M Sell
358,040
-154,356
-30% -$1.44M 0.01% 935
2023
Q3 		$5.23M Sell
512,396
-397,552
-44% -$3.7M 0.01% 745
2023
Q2 		$6.85M Buy
909,948
+203,814
+29% +$1.65M 0.01% 660
2023
Q1 		$6.25M Sell
706,134
-270,395
-28% -$2.67M 0.01% 760
2022
Q4 		$8.91M Sell
976,529
-218,101
-18% -$1.9M 0.01% 812
2022
Q3 		$9.64M Buy
1,194,630
+667,636
+127% +$5.9M 0.01% 779
2022
Q2 		$3.96M Buy
526,994
+147,118
+39% +$1.28M ﹤0.01% 1057
2022
Q1 		$3.57M Buy
379,876
+112,763
+42% +$941K ﹤0.01% 1126
2021
Q4 		$2.14M Buy
267,113
+79,051
+42% +$713K ﹤0.01% 1616
2021
Q3 		$1.83M Buy
188,062
+151,844
+419% +$1.42M ﹤0.01% 1696
2021
Q2 		$359K Sell
36,218
-1,421
-4% -$15K ﹤0.01% 2298
2021
Q1 		$434K Sell
37,639
-403,639
-91% -$4.63M ﹤0.01% 2436
2020
Q4 		$4.26M Sell
441,278
-84,282
-16% -$807K ﹤0.01% 1500
2020
Q3 		$4.74M Sell
525,560
-390,931
-43% -$4.14M ﹤0.01% 1344
2020
Q2 		$11.3M Buy
916,491
+295,493
+48% +$3.34M 0.01% 726
2020
Q1 		$5.58M Sell
620,998
-141,876
-19% -$1.45M 0.01% 835
2019
Q4 		$7.48M Buy
762,874
+449,053
+143% +$4.01M 0.01% 757
2019
Q3 		$2.16M Sell
313,821
-59,705
-16% -$457K ﹤0.01% 1108
2019
Q2 		$3.45M Buy
373,526
+190,190
+104% +$2.29M ﹤0.01% 857
2019
Q1 		$2.88M Buy
183,336
+92,871
+103% +$1.64M ﹤0.01% 869
2018
Q4 		$1.4M Buy
90,465
+63,204
+232% +$1.3M ﹤0.01% 1200
2018
Q3 		$587K Sell
27,261
-303,920
-92% -$7.06M ﹤0.01% 1399
2018
Q2 		$8.05M Sell
331,181
-350,463
-51% -$7.15M 0.01% 490
2018
Q1 		$11.6M Buy
681,644
+482,747
+243% +$9.43M 0.02% 349
2017
Q4 		$3.77M Buy
+198,897
New +$2.99M 0.01% 695
2017
Q3 		– Sell
-74,641
Closed -$1.68M – 3242
2017
Q2 		$2.48M Buy
+74,641
New +$2.31M ﹤0.01% 769
2017
Q1 		– Sell
-13,612
Closed -$493K – 4612
2016
Q4 		$493K Sell
13,612
-57,272
-81% -$2.29M ﹤0.01% 1514
2016
Q3 		$3.26M Buy
+70,884
New +$3.7M 0.01% 837
2016
Q2 		– Sell
-4,540
Closed -$243K – 3520
2016
Q1 		$243K Sell
4,540
-4,789
-51% -$281K ﹤0.01% 1698
2015
Q4 		$612K Buy
+9,329
New +$577K ﹤0.01% 1459
2014
Q2 		– Sell
-34,127
Closed -$1.74M – 4305
2014
Q1 		$1.8M Buy
+34,127
New +$1.58M 0.01% 606

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallax Volatility Advisers's TEVA Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 117,708 shares — an estimated $3.67M sold.

Parallax Volatility Advisers first reported a position in TEVA in Q1 2014 and held it in 38 quarters. The position peaked at $25M in Q4 2024. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 117,708 Teva Pharmaceuticals shares in Q1 2026, an estimated $3.67M.
  • Parallax Volatility Advisers first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 38 quarters.
  • Parallax Volatility Advisers's Teva Pharmaceuticals position peaked at $25M in Q4 2024.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.